Kazano brand medicine goes by the trade name Viptomet in Europe.
Information about Kazano
Kazano is a prescription medication that combines two active ingredients, alogliptin and metformin, and is primarily used to manage blood sugar levels in adults with type 2 diabetes. The combination aims to enhance glycemic control by utilizing different mechanisms of action.
Product Highlights
- Kazano is indicated for:
- The management of type 2 diabetes mellitus in conjunction with diet and exercise.
- It may be used alone or in combination with other antidiabetic agents.
Key Ingredient
Key Benefits
- Targets different pathways to lower blood glucose levels.
- Generally does not cause weight gain, unlike some other diabetes medications.
- Lower risk compared to sulfonylureas when used appropriately.
Direction of Use
- Typically taken once daily with food to reduce gastrointestinal side effects.
- Regular blood glucose monitoring and periodic HbA1c tests are recommended to assess effectiveness.
Safety Concerns
- Common side effects include nausea, diarrhea, and abdominal discomfort, especially when initiating treatment.
- A rare but serious condition associated with metformin, particularly in patients with renal impairment or other risk factors.
Avoid Kazano (Alogliptin / Metformin) If
- You have a history of hypersensitivity to alogliptin, metformin, or any components of the formulation.
- You have severe renal impairment or end-stage renal disease.
- You have metabolic acidosis, such as diabetic ketoacidosis.
- You are pregnant or breastfeeding without medical advice.
